Skip to main content
Erschienen in: International Urogynecology Journal 5/2016

25.09.2015 | Review Article

Hormonal contraception and pelvic floor function: a systematic review

verfasst von: Rita Champaneria, Ruben Mamprin D’Andrea, Pallavi M. Latthe

Erschienen in: International Urogynecology Journal | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Hormonal contraceptive use is common practice worldwide. Although the effects of hormone treatments in the pelvic region are well established, there is no clear evidence regarding their effects on incontinence, bladder, bowel, vaginal and sexual symptoms in premenopausal women. We hypothesized that hormonal contraceptives affect pelvic floor function. We therefore performed a comprehensive systematic review of published studies to determine the influence of hormonal contraception on pelvic floor functions.

Methods

Electronic literature databases were searched from database inception to March 2015. Keywords and medical subject headings searched for included terms and word variations for ‘contraception’, and ‘bowel’, ‘vaginal’, ‘sexual’ and ‘urinary’ symptoms. Studies were eligible if they looked at these symptoms in women taking hormonal contraception. Two reviewers independently screened studies for inclusion, and extracted data on study characteristics, quality and results. Data were combined where possible.

Results

Of the 429 citations identified, 13 studies were included in the review. Data were meta-analysed where possible and presented as prevalence. The results indicate statistically significant links between interstitial cystitis and oral contraceptive use at any point (ever) (OR 2.31, 95 % CI 1.03 – 5.16; p = 0.04) and vulvar vestibulitis and current oral contraceptive use (OR 2.10, 95 % CI 1.26 – 3.49; p = 0.004). The evidence is unclear in other areas.

Conclusions

Our results indicate that oral contraceptives may have an effect on pelvic floor function. They could increase the risk of painful bladder and vulvar vestibulitis, but their effect on dyspareunia is inconsistent. However, robustly collected prospective data to establish causal associations are needed.
Literatur
2.
Zurück zum Zitat Iliadou A, Milsom I, Pedersen NL, Altman D (2009) Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register. Fertil Steril 92(2):428–433CrossRefPubMedPubMedCentral Iliadou A, Milsom I, Pedersen NL, Altman D (2009) Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register. Fertil Steril 92(2):428–433CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62(4 Suppl 1):45–51CrossRefPubMed Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62(4 Suppl 1):45–51CrossRefPubMed
4.
Zurück zum Zitat Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A (2012) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 10:CD001405PubMed Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A (2012) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 10:CD001405PubMed
5.
Zurück zum Zitat O'Halloran T, Bell RJ, Robinson PJ, Davis SR (2012) Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Intern Med 157(2):87–93CrossRefPubMed O'Halloran T, Bell RJ, Robinson PJ, Davis SR (2012) Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Intern Med 157(2):87–93CrossRefPubMed
6.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed
7.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 17:1–12CrossRefPubMed Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 17:1–12CrossRefPubMed
8.
Zurück zum Zitat Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S (1995) Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 16:62–73CrossRefPubMed Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S (1995) Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 16:62–73CrossRefPubMed
10.
Zurück zum Zitat Heliovaara-Peippo S, Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A et al (2010) The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial. BJOG 117(5):602–609CrossRefPubMed Heliovaara-Peippo S, Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A et al (2010) The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial. BJOG 117(5):602–609CrossRefPubMed
11.
Zurück zum Zitat Foster DC, Woodruff JD (1995) Case-control study of vulvar vestibulitis syndrome. J Womens Health 4(6):677–680CrossRef Foster DC, Woodruff JD (1995) Case-control study of vulvar vestibulitis syndrome. J Womens Health 4(6):677–680CrossRef
12.
Zurück zum Zitat Townsend MK, Curhan GC, Resnick NM, Grodstein F (2009) Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol 181(5):2170–2175CrossRefPubMedPubMedCentral Townsend MK, Curhan GC, Resnick NM, Grodstein F (2009) Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol 181(5):2170–2175CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bouchard C, Brisson J, Fortier M, Morin C, Blanchette C (2002) Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol 156(3):254–261CrossRefPubMed Bouchard C, Brisson J, Fortier M, Morin C, Blanchette C (2002) Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol 156(3):254–261CrossRefPubMed
14.
Zurück zum Zitat Edgardh K, Abdelnoor M (2007) Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo. Acta Derm Venereol 87(4):350–354CrossRefPubMed Edgardh K, Abdelnoor M (2007) Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo. Acta Derm Venereol 87(4):350–354CrossRefPubMed
15.
Zurück zum Zitat Gardella B, Porru D, Nappi RE, Dacco MD, Chiesa A, Spinillo A (2011) Interstitial cystitis is associated with vulvodynia and sexual dysfunction – a case-control study. J Sex Med 8(6):1726–1734CrossRefPubMed Gardella B, Porru D, Nappi RE, Dacco MD, Chiesa A, Spinillo A (2011) Interstitial cystitis is associated with vulvodynia and sexual dysfunction – a case-control study. J Sex Med 8(6):1726–1734CrossRefPubMed
16.
Zurück zum Zitat Warren JW, Clauw DJ, Wesselmann U, Langenberg PW, Howard FM, Morozov V (2011) Sexuality and reproductive risk factors for interstitial cystitis/painful bladder syndrome in women. Urology 77(3):570–575CrossRefPubMed Warren JW, Clauw DJ, Wesselmann U, Langenberg PW, Howard FM, Morozov V (2011) Sexuality and reproductive risk factors for interstitial cystitis/painful bladder syndrome in women. Urology 77(3):570–575CrossRefPubMed
17.
Zurück zum Zitat Burgio KL, Zyczynski H, Locher JL, Richter HE, Redden DT, Wright KC (2003) Urinary Incontinence in the 12-month postpartum period. Obstet Gynecol 102(6):1291–1298PubMed Burgio KL, Zyczynski H, Locher JL, Richter HE, Redden DT, Wright KC (2003) Urinary Incontinence in the 12-month postpartum period. Obstet Gynecol 102(6):1291–1298PubMed
18.
Zurück zum Zitat Ekin M, Cengiz H, Ayag ME, Kaya C, Yasar L, Savan K (2013) Effects of the levonorgestrel-releasing intrauterine system on urinary symptoms in patients with adenomyosis. Eur J Obstet Gynecol Reprod Biol 170:517–520CrossRefPubMed Ekin M, Cengiz H, Ayag ME, Kaya C, Yasar L, Savan K (2013) Effects of the levonorgestrel-releasing intrauterine system on urinary symptoms in patients with adenomyosis. Eur J Obstet Gynecol Reprod Biol 170:517–520CrossRefPubMed
19.
Zurück zum Zitat Fraser IS, Dennerstein GJ (1994) Depo-Provera use in an Australian metropolitan practice. Med J Aust 160(9):553–556PubMed Fraser IS, Dennerstein GJ (1994) Depo-Provera use in an Australian metropolitan practice. Med J Aust 160(9):553–556PubMed
20.
Zurück zum Zitat Reed BD, Harlow SD, Legocki LJ, Helmuth ME, Haefner HK, Gillespie BW et al (2013) Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study. BJOG 120(13):1678–1684CrossRefPubMedPubMedCentral Reed BD, Harlow SD, Legocki LJ, Helmuth ME, Haefner HK, Gillespie BW et al (2013) Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study. BJOG 120(13):1678–1684CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Smith NK, Jozkowski KN, Sanders SA (2014) Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med 11:462–470CrossRefPubMed Smith NK, Jozkowski KN, Sanders SA (2014) Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med 11:462–470CrossRefPubMed
22.
Zurück zum Zitat Robinson D, Toozs-Hobson P, Cardozo L (2013) The effect of hormones on the lower urinary tract. Menopause 19(4):155–162CrossRef Robinson D, Toozs-Hobson P, Cardozo L (2013) The effect of hormones on the lower urinary tract. Menopause 19(4):155–162CrossRef
23.
24.
Zurück zum Zitat Cheng Y, Keast JR (2009) Effects of estrogens and bladder inflammation on mitogen-activated protein kinases in lumboscaral dorsal root ganglia from adult female rats. BMC Neurosci 10:156CrossRefPubMedPubMedCentral Cheng Y, Keast JR (2009) Effects of estrogens and bladder inflammation on mitogen-activated protein kinases in lumboscaral dorsal root ganglia from adult female rats. BMC Neurosci 10:156CrossRefPubMedPubMedCentral
Metadaten
Titel
Hormonal contraception and pelvic floor function: a systematic review
verfasst von
Rita Champaneria
Ruben Mamprin D’Andrea
Pallavi M. Latthe
Publikationsdatum
25.09.2015
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 5/2016
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-015-2833-3

Weitere Artikel der Ausgabe 5/2016

International Urogynecology Journal 5/2016 Zur Ausgabe

Urogynecology Digest

Urogynecology digest

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.